Skip to content

Pacific Biosciences of California PACB Goodwill And Intangible Asset Impairment

Goodwill And Intangible Asset Impairment at other companies

Azenta logo
AzentaAZTA

Segments

By segment

See full
Reportable Segment$0-100%

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAndIntangibleAssetImpairment.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's goodwill and intangible asset impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's goodwill and intangible asset impairment?
Pacific Biosciences of California (PACB) reported goodwill and intangible asset impairment of $0 in Q1 2026.
How has Pacific Biosciences of California's goodwill and intangible asset impairment changed year-over-year?
Pacific Biosciences of California's goodwill and intangible asset impairment decreased by 100.0% year-over-year, from $15M to $0.
What does goodwill and intangible asset impairment mean?
This represents a non-cash charge recognized when the carrying value of goodwill or intangible assets exceeds their fair value. It indicates that the expected future economic benefits from previous acquisitions have declined. Frequent or large impairment charges often signal overpayment for past acquisitions or a deterioration in the underlying business performance.